Vera Therapeutics Financials
| VERA Stock | USD 48.31 1.28 2.72% |
Vera |
Understanding current and past Vera Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Vera Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Vera Therapeutics' assets may result in an increase in income on the income statement.
Please note, the presentation of Vera Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vera Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Vera Therapeutics' management manipulating its earnings.
Vera Therapeutics Stock Summary
Vera Therapeutics competes with Third Harmonic, Cullinan Oncology, Edgewise Therapeutics, Rallybio Corp, and Monte Rosa. Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California. Vera Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US92337R1014 |
| CUSIP | 92337R101 |
| Location | California; U.S.A |
| Business Address | 8000 Marina Boulevard, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | veratx.com |
| Phone | 650 770 0077 |
| Currency | USD - US Dollar |
Vera Therapeutics Key Financial Ratios
| Return On Equity | -0.65 | ||||
| Return On Asset | -0.33 | ||||
| Target Price | 64.58 | ||||
| Number Of Employees | 82 | ||||
| Beta | 1.02 |
Vera Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vera Therapeutics's current stock value. Our valuation model uses many indicators to compare Vera Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vera Therapeutics competition to find correlations between indicators driving Vera Therapeutics's intrinsic value. More Info.Vera Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vera Therapeutics' earnings, one of the primary drivers of an investment's value.Vera Therapeutics Systematic Risk
Vera Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Vera Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Vera Therapeutics correlated with the market. If Beta is less than 0 Vera Therapeutics generally moves in the opposite direction as compared to the market. If Vera Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Vera Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Vera Therapeutics is generally in the same direction as the market. If Beta > 1 Vera Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
About Vera Therapeutics Financials
What exactly are Vera Therapeutics Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Vera Therapeutics' income statement, its balance sheet, and the statement of cash flows. Potential Vera Therapeutics investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Vera Therapeutics investors may use each financial statement separately, they are all related. The changes in Vera Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vera Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Vera Therapeutics Thematic Clasifications
Vera Therapeutics is part of Pharmaceutical Products investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Pharmaceutical Products | View |
Vera Therapeutics November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Vera Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Vera Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Vera Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Vera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Vera Therapeutics's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.28 | |||
| Information Ratio | 0.0867 | |||
| Maximum Drawdown | 24.44 | |||
| Value At Risk | (5.08) | |||
| Potential Upside | 6.27 |
Complementary Tools for Vera Stock analysis
When running Vera Therapeutics' price analysis, check to measure Vera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vera Therapeutics is operating at the current time. Most of Vera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vera Therapeutics' price. Additionally, you may evaluate how the addition of Vera Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |